Additionally, Tau- and Aβ-containing EVs derived from a variety of in vitro and in vivo sources were shown to be taken up by recipient cells in vitro and in vivo, highlighting their potential as vehicles to spread AD-related proteins. Here, MAPT is linked to Alzheimer disease.